v3.26.1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Operating activities    
Net income (loss) $ (120,256) $ 47,677
Adjustments to reconcile net income (loss) to net cash provided by operating activities:    
Depreciation and amortization 20,611 11,938
Share-based compensation 555,963 414,660
Deferred income taxes (1,368) (27,999)
Non-cash charitable contributions 12,198 13,495
Net amortization of investment premium and discount (5,428) (9,513)
Other (570) 16,892
Changes in assets and liabilities:    
Accounts receivable 95,004 135,297
Prepaid expenses and other assets (27,746) (22,853)
Operating lease right-of-use assets 19,730 14,245
Accounts payable (8,433) 8,752
Accrued expenses and other liabilities 102,417 (14,285)
Operating lease liabilities (21,214) (16,907)
Net cash provided by operating activities 620,908 571,399
Investing activities    
Purchases of property and equipment (39,293) (18,299)
Purchases of marketable securities (438,808) (878,311)
Sales of marketable securities 436,611 12,890
Maturities of marketable securities 647,214 809,600
Acquisition of business, net of cash acquired (446,954) 0
Net cash provided by (used in) investing activities 158,770 (74,120)
Financing activities    
Proceeds from exercise of stock options, net 0 8,053
Repurchases of Class A common stock (2,024,886) (227,626)
Shares repurchased for tax withholdings on release of restricted stock units and restricted stock awards (180,532) (199,468)
Proceeds from issuance of convertible notes, net of issuance costs [1] 979,894 0
Purchase of capped calls related to convertible notes (99,187) 0
Other financing activities (1,890) 0
Net cash used in financing activities (1,326,601) (419,041)
Effect of exchange rate changes on cash, cash equivalents and restricted cash 50 2,278
Net increase (decrease) in cash, cash equivalents and restricted cash (546,873) 80,516
Cash, cash equivalents and restricted cash, beginning of period 975,362 1,141,221
Cash, cash equivalents and restricted cash, end of period 428,489 1,221,737
Reconciliation of cash, cash equivalents and restricted cash to condensed consolidated balance sheets    
Cash and cash equivalents 422,484 1,216,941
Restricted cash included in other assets 6,005 4,796
Total cash, cash equivalents and restricted cash 428,489 1,221,737
Supplemental cash flow information    
Cash paid for income taxes, net 11,600 14,079
Non-cash investing and financing activities:    
Excise tax on repurchases of Class A common stock in accrued expenses and other current liabilities $ 14,939 $ 0
[1] Includes amounts attributable to related party transactions. Refer to Note 12 of our condensed consolidated financial statements for further information on related party arrangements.